Loading company…
Meliodays Medical develops a hormone-free intrauterine device intended to relieve menstrual pain.
Meliodays Medical is developing MelioOne, an intrauterine device designed to release medication locally over one year. The product is in the prototyping phase and targets people with severe menstrual pain. Founded in 2022, the company is based in Munich, Germany. It raised EUR 800,000 in pre-seed funding in March 2025, led by capacura.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in